Bronchoplastic procedures in malignant and nonmalignant disease

Abstract

Bronchoplastic procedures for central tumors and sleeve pneumonectomies are associated with poor survival. Careful selection of these patients, as well as of patients with impaired lung function and cardiovascular risk factors, is mandatory.

Factors affecting survival after bronchoplasty and broncho-angioplasty for lung cancer: single institutional review of 147 patients

“…In most of the other series, multivariate analysis has shown that long-term survival in patients treated with bronchoplasty or broncho-angioplasty was influenced mainly by the nodal stage or advanced tumor stage [10,11,17]. End et al [11] showed that the presence of respiratory or cardiovascular risk was associated with a poor outcome along with advanced tumor stage and the type of bronchoplastic procedure; however, their data included a small number of sleeve pneumonectomy cases with a 25% 1-year survival.…”

“…End et al [11] showed that the presence of respiratory or cardiovascular risk was associated with a poor outcome along with advanced tumor stage and the type of bronchoplastic procedure; however, their data included a small number of sleeve pneumonectomy cases with a 25% 1-year survival. In the current series, the presence of nonsquamous cell carcinoma on histology, advanced nodal status, bronchoangioplasty, and postoperative complications were all risk factors for a poor outcome, whereas the preoperative respiratory risk and adjuvant therapy were not significant risk factors.…”

“…There were 135 male and 12 female patients, with a mean age of 63.4 AE 9.7 years (range, 8-78 years). Thirty-two (21.8%) patients had a preoperative respiratory risk (chronic obstructive pulmonary disease, defined as a preoperative forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) 60% of predicted value) [11]. Table 1 shows the clinical characteristics of the bronchoplasty and the broncho-angioplasty groups.…”

Short-term outcome of bronchial sleeve lobectomy

“…This survival rate was comparable or even better than survival after pneumonectomy, provided that a complete resection can be achieved. Multivariate analysis has shown that nodal status and advanced tumor stage were the most significant factors related to long-term survival, with N2 disease having a definitely negative effect compared with N0 or N1 disease 11,20,21 . Mehran et al demonstrated a significant difference in survival between N1 and N2 disease with none of the patients with N2 disease were alive 5 years after the sleeve lobectomy; they found no significant difference between N0 and N1 disease after sleeve resection 22 .…”

Bronchoplastic lobectomy: do early results depend on the underlying pathology?A comparison between typical carcinoids and primary lung cancer

“…Most studies report complications independently from the type of tumours [3,[6][7][8][9]. Only two studies looked into the influence of the underlying pathology on the rate of complications.…”